Asston Pharmaceuticals: FY26 Audited Financial Results Approved

Asston Pharmaceuticals Ltd. announced the approval of its audited financial results for the financial year ended March 31, 2026, during a Board of Directors meeting held on May 29, 2026. The meeting, conducted via video conferencing, commenced at 03:00 P.M. and concluded at 07:10 P.M. The approved financial statements and results, along with the audit report, comply with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Panchal S K & Associates, Chartered Accountants, conducted the independent audit, expressing an opinion that the financial results present a true and fair view in accordance with applicable accounting standards.